Article
Tumour mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade
medRxiv · 2023 · Mahmood, M.; Liu, E. M.; Shergold, A. L.; Tolla, E.; Tait-Mulder, J.; Uribe, A. H.; Shokry, E.; Young, A. L.; Lilla, S.; Kim, M.; Park, T.; Manchon, J. L.; Rodriguez-Antona, C.; Walters, R. C.; Springett, R. J.; Blaza, J. N.; Zanivan, S.; Sumpton, D. A.; Roberts, E. W.; Reznik, E.; Gammage, P. A.
Key facts
| Title | Tumour mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade |
|---|---|
| First author | Mahmood, M.; Liu, E. M.; Shergold, A. L.; Tolla, E.; Tait-Mulder, J.; Uribe, A. H.; Shokry, E.; Young, A. L.; Lilla, S.; Kim, M.; Park, T.; Manchon, J. L.; Rodriguez-Antona, C.; Walters, R. C.; Springett, R. J.; Blaza, J. N.; Zanivan, S.; Sumpton, D. A.; Roberts, E. W.; Reznik, E.; Gammage, P. A. |
| Journal | medRxiv |
| Published | Mar 23, 2023 |
| DOI | 10.1101/2023.03.21.533091 |
| Devices mentioned | BK110039, K810863, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185 and 5 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, DBM, KLB and 8 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1